Edition:
India

CytRx Corp (CYTR.OQ)

CYTR.OQ on NASDAQ Stock Exchange Capital Market

0.56USD
12:20am IST
Change (% chg)

$0.00 (+0.04%)
Prev Close
$0.56
Open
$0.55
Day's High
$0.56
Day's Low
$0.55
Volume
14,270
Avg. Vol
25,672
52-wk High
$2.01
52-wk Low
$0.35

About

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue... (more)

Overall

Beta: 2.18
Market Cap(Mil.): $18.76
Shares Outstanding(Mil.): 33.64
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates